Home Other Building Blocks beta-propiolactone

beta-propiolactone

CAS No.:
57-57-8
Catalog Number:
AG003772
Molecular Formula:
C3H4O2
Molecular Weight:
72.0627
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG003772
Chemical Name:
beta-propiolactone
CAS Number:
57-57-8
Molecular Formula:
C3H4O2
Molecular Weight:
72.0627
MDL Number:
MFCD00005169
IUPAC Name:
oxetan-2-one
InChI:
InChI=1S/C3H4O2/c4-3-1-2-5-3/h1-2H2
InChI Key:
VEZXCJBBBCKRPI-UHFFFAOYSA-N
SMILES:
C1COC1=O
EC Number:
200-340-1
UNII:
6RC3ZT4HB0
RTECS Number:
RQ7350000
UN Number:
2810
Properties
Complexity:
57.9  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
72.021g/mol
Formal Charge:
0
Heavy Atom Count:
5  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
72.063g/mol
Monoisotopic Mass:
72.021g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
26.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.2  
Literature
Title Journal
In vitro and in vivo isolation and characterization of Duvenhage virus. PLoS pathogens 20120501
4-[(2-Carb-oxy-eth-yl)amino]-benzoic acid monohydrate. Acta crystallographica. Section E, Structure reports online 20120401
Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands. Vaccine 20120111
Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. International journal of nanomedicine 20120101
Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity. PloS one 20120101
Immune responses in pigs vaccinated with adjuvanted and non-adjuvanted A(H1N1)pdm/09 influenza vaccines used in human immunization programmes. PloS one 20120101
West Nile virus: characterization and diagnostic applications of monoclonal antibodies. Virology journal 20120101
A caprine herpesvirus 1 vaccine adjuvanted with MF59™ protects against vaginal infection and interferes with the establishment of latency in goats. PloS one 20120101
Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus. PloS one 20120101
Avian paramyxovirus serotype-1: a review of disease distribution, clinical symptoms, and laboratory diagnostics. Veterinary medicine international 20120101
Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo. PloS one 20120101
Simultaneous measurement of benzo[a]pyrene-induced Pig-a and lacZ mutations, micronuclei and DNA adducts in Muta™ Mouse. Environmental and molecular mutagenesis 20111201
[The characterization analysis of HAV recombinant antigen was expressed by vaccinia virus vector]. Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20111201
Effect of the β-propiolactone treatment on the adsorption and fusion of influenza A/Brisbane/59/2007 and A/New Caledonia/20/1999 virus H1N1 on a dimyristoylphosphatidylcholine/ganglioside GM3 mixed phospholipids monolayer at the air-water interface. Langmuir : the ACS journal of surfaces and colloids 20111115
Reactions of beta-propiolactone with nucleobase analogues, nucleosides, and peptides: implications for the inactivation of viruses. The Journal of biological chemistry 20111021
The cap'n'collar transcription factor Nrf2 mediates both intrinsic resistance to environmental stressors and an adaptive response elicited by chemopreventive agents that determines susceptibility to electrophilic xenobiotics. Chemico-biological interactions 20110630
Immunogenicity and protective efficacy in dogs of an MF59™-adjuvanted vaccine against recombinant canine/porcine coronavirus. Vaccine 20110303
The assessment of efficacy of porcine reproductive respiratory syndrome virus inactivated vaccine based on the viral quantity and inactivation methods. Virology journal 20110101
A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease. PloS one 20110101
Seroprevalence and distribution of arboviral infections among rural Kenyan adults: a cross-sectional study. Virology journal 20110101
Formulation of a killed whole cell pneumococcus vaccine - effect of aluminum adjuvants on the antibody and IL-17 response. Journal of immune based therapies and vaccines 20110101
β‑Propiolactone. Report on carcinogens : carcinogen profiles 20110101
Infection of differentiated porcine airway epithelial cells by influenza virus: differential susceptibility to infection by porcine and avian viruses. PloS one 20110101
GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis. Vaccine 20101103
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Isolation of a 2-oxetanone from the fruits of Synsepalum dulcificum. Natural product research 20101101
Hemagglutinin displayed baculovirus protects against highly pathogenic influenza. Vaccine 20101004
Immunogenicity and protective efficacy in mice and hamsters of a β-propiolactone inactivated whole virus SARS-CoV vaccine. Viral immunology 20101001
Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria. PLoS neglected tropical diseases 20100701
Molecular identification of the vaccine strain from the inactivated oil emulsion H9N2 low pathogenic avian influenza vaccine. Journal of veterinary science 20100601
Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus. PLoS neglected tropical diseases 20100601
Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity. Vaccine 20100514
Use of the hemagglutinating virus of Japan (HVJ) envelope as a versatile delivery system for nucleic acids and proteins to leukocytes in vitro. Current protocols in immunology 20100401
Safety and efficacy of an inactivated Carbopol-adjuvanted goose haemorrhagic polyomavirus vaccine for domestic geese. Avian pathology : journal of the W.V.P.A 20100401
The influence of the inactivating agent on the antigen content of inactivated Newcastle disease vaccines assessed by the in vitro potency test. Biologicals : journal of the International Association of Biological Standardization 20100101
Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957. PloS one 20100101
Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India. BMC infectious diseases 20100101
Retrospective analysis of suspected rabies cases reported at bugando referral hospital, mwanza, Tanzania. Journal of global infectious diseases 20100101
Combined experimental and theoretical study on hydrogen-bonded complexes between cyclic ketones, lactones, and lactams with 3,4-dinitrophenol. The journal of physical chemistry. A 20091231
Pandemic influenza vaccines - the challenges. Viruses 20091201
Quantitative determination of the infectivity of the proviral DNA of a retrovirus in vitro: Evaluation of methods for DNA inactivation. Biologicals : journal of the International Association of Biological Standardization 20090801
Matrix photochemistry, photoelectron spectroscopy, solid-phase structure, and ring strain energy of beta-propiothiolactone. The journal of physical chemistry. A 20090416
Serological response in cattle immunized with inactivated oil and Algel adjuvant vaccines against infectious bovine rhinotracheitis. The new microbiologica 20090401
Poly(lactide-co-glycolide) microspheres: a potent oral delivery system to elicit systemic immune response against inactivated rabies virus. Vaccine 20090326
Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo. Biochimica et biophysica acta 20090101
A pilot study of the immune response to whole inactivated avian influenza H7N1 virus vaccine in mice. Influenza and other respiratory viruses 20090101
Induction of cell-cell fusion by ectromelia virus is not inhibited by its fusion inhibitory complex. Virology journal 20090101
From where did the 2009 'swine-origin' influenza A virus (H1N1) emerge? Virology journal 20090101
Validation of betapropiolactone (BPL) as an inactivant for infectious bovine rhinotracheitis (IBR) virus. Research in veterinary science 20081201
Efficiency of Matricaria chamomilla CH12 and number of doses of rabies vaccine on the humoral immune response in cattle. Journal of veterinary science 20081201
Inactivated infectious haematopoietic necrosis virus (IHNV) vaccines. Journal of fish diseases 20081001
Chemical reactivity and biological activity of diketene. Chemical research in toxicology 20081001
Development of stable influenza vaccine powder formulations: challenges and possibilities. Pharmaceutical research 20080601
The mannose receptor mediates dengue virus infection of macrophages. PLoS pathogens 20080201
6-sulfo sialyl Lewis X is the common receptor determinant recognized by H5, H6, H7 and H9 influenza viruses of terrestrial poultry. Virology journal 20080101
Chemical addressability of ultraviolet-inactivated viral nanoparticles (VNPs). PloS one 20080101
Enzymatic synthesis of poly(hydroxyalkanoates) in ionic liquids. Journal of biotechnology 20071101
A sensitive cell-based assay for the detection of residual infectious West Nile virus. Vaccine 20070928
Influenza: the virus and prophylaxis with inactivated influenza vaccine in 'at risk' groups, including COPD patients. International journal of chronic obstructive pulmonary disease 20070901
Making a difference on excited-state chemistry by controlling free space within a nanocapsule: photochemistry of 1-(4-alkylphenyl)-3-phenylpropan-2-ones. Organic letters 20070830
Ab initio study of the reaction of propionyl (C2H5CO) radical with oxygen (O2). The Journal of chemical physics 20070807
Quantification of growth factors in allogenic bone grafts extracted with three different methods. Cell and tissue banking 20070601
Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines. Biotechnology and bioengineering 20070501
Frequencies of mutagen-induced coincident mitotic recombination at unlinked loci in Saccharomyces cerevisiae. Mutation research 20070301
Intravaginal administration of an inactivated vaccine prevents lesions induced by caprine herpesvirus-1 in goats. Vaccine 20070219
Reactivity of indanedioneketene dimer with amines. The Journal of organic chemistry 20070119
Efficacy and safety of two whole IgG polyvalent antivenoms, refined by caprylic acid fractionation with or without beta-propiolactone, in the treatment of Bothrops asper bites in Colombia. Transactions of the Royal Society of Tropical Medicine and Hygiene 20061201
[The development of mucosal vaccines]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20061102
Structures of heterogeneous proton-bond dimers with a high dipole moment monomer: covalent vs electrostatic interactions. The journal of physical chemistry. A 20060511
Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine. Vaccine 20060213
Clinical responses of patients with Kawasaki disease to different brands of intravenous immunoglobulin. The Journal of pediatrics 20060101
Ru-catalyzed alkene-alkyne coupling. Total synthesis of amphidinolide P. Journal of the American Chemical Society 20051221
Ophiopojaponin D, a new phenylpropanoid glycoside from Ophiopogon japonicus Ker-Gawl. Archives of pharmacal research 20051101
Augmentation of immune responses to SARS coronavirus by a combination of DNA and whole killed virus vaccines. Vaccine 20050815
SARS vaccine protective in mice. Emerging infectious diseases 20050801
A kinetic approach to the alkylating potential of carcinogenic lactones. Chemical research in toxicology 20050701
[Conditions for SARS-CoV cultivation and inactivation]. Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20050601
Dengue type 3 virus, Saint Martin, 2003-2004. Emerging infectious diseases 20050501
Role of activation function domain-1, DNA binding, and coactivator GRIP1 in the expression of partial agonist activity of glucocorticoid receptor-antagonist complexes. Biochemistry 20050308
[Development of purified HFRS bivalent vaccine]. Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 20050301
Profile of animal bite cases in Pune. The Journal of communicable diseases 20050301
Reactivity of lactones and GHB formation. The Journal of organic chemistry 20050121
Anticomplementary activity of equine whole IgG antivenoms: comparison of three fractionation protocols. Toxicon : official journal of the International Society on Toxinology 20050101
Modulation of macrophage functions by sheeppox virus provides clues to understand interaction of the virus with host immune system. Virology journal 20050101
Molecular advances in the cell biology of SARS-CoV and current disease prevention strategies. Virology journal 20050101
Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry. Biochemical and biophysical research communications 20041210
Vero-cell rabies vaccine produced using serum-free medium. Vaccine 20041209
Establishment of batch 4 of the Biological Reference Preparation (BRP) for rabies vaccine (inactivated) for veterinary use. Pharmeuropa bio 20041201
[Direct identification of Ophiogon japonicus (Thunb.)Ker-Gawl. from its confusable varieties by second derivative FTIR spectroscopy combined with statistics]. Guang pu xue yu guang pu fen xi = Guang pu 20040901
Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB/c mice. DNA and cell biology 20040601
In vitro inactivation of the rabies virus by ascorbic acid. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20040101
The effect of chemical inactivation of bovine viral diarrhea virus with beta-propiolactone and binary ethyleneimine on plasma proteins and coagulation factors. The Egyptian journal of immunology 20040101
ß-Propiolactone. Report on carcinogens : carcinogen profiles 20040101
Development of a non-immunising, paraspecific vaccine from attenuated pox viruses: a new type of vaccine. The new microbiologica 20030101
Platelet adhesion onto segmented polyurethane surfaces modified by carboxybetaine. Journal of biomaterials science. Polymer edition 20030101
Effect of beta propiolactone viral inactivation on alpha1 antitrypsin values. Journal of clinical pathology 20020901
Conformation-dependent reaction thermochemistry: study of lactones and lactone enolates in the gas phase. Journal of the American Chemical Society 20020508
Serine and threonine beta-lactones: a new class of hepatitis A virus 3C cysteine proteinase inhibitors. The Journal of organic chemistry 20020308
beta-Propiolactone. Report on carcinogens : carcinogen profiles 20020101
Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine. Vaccine 20010914
Glycidol degrades scrapie mouse prion protein. The Journal of veterinary medical science 20010901
New antiprogestins with partial agonist activity: potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties. Molecular endocrinology (Baltimore, Md.) 20010201
Inactivation of an astrovirus associated with poult enteritis mortality syndrome. Avian diseases 20010101
[Development of of non-immunising, paraspecific vaccine from attenuated pox viruses: a new type of vaccine]. Berliner und Munchener tierarztliche Wochenschrift 20010101
Long-term follow-up of HIV-1-infected Thai patients immunized with Remune monotherapy. HIV clinical trials 20010101
Synthesis of poly(2-methyl-3-hydroxyoctanoate) via anionic polymerization of alpha-methyl-beta-pentyl-beta-propiolactone. Biomacromolecules 20010101
A vanadium/aspirin complex controlled release using a poly(beta-propiolactone) film. Effects on osteosarcoma cells. Journal of biomaterials science. Polymer edition 20010101
[Clinical trial of YU BHK Rabivak vaccine against rabies in volunteers]. Medicinski pregled 20010101
Inactivation of hepatitis viruses and HIV in plasma and plasma derivatives by treatment with beta-propiolactone/UV irradiation. Current studies in hematology and blood transfusion 19890101
Properties